Furthermore, several other kinesin inhibitors, such as KIF15-IN-1 (a synergistic inhibitor of Eg5) targeting KIF15, produces an effective suppression on tumor growth by combining with Eg5 inhibitors, which may be expected to overcome chemo-resistance during ispinesib monotherapy [176, 177]. Here, KIF11 is linked to neoplasm.